Chinese herbal formula for rheumatoid arthritis with kidney deficiency
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial tests a Chinese herbal formula (Bushen Quhan Zhiwang decoction) to help people with rheumatoid arthritis who also have a pattern of 'kidney deficiency and excessive cold' achieve deeper remission. It may be an option if your disease is mild to moderate and you are on a stable single medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have rheumatoid arthritis diagnosed by a doctor (using standard criteria).
- You also have a specific Chinese medicine pattern called 'kidney deficiency and excessive cold syndrome' (e.g., cold limbs, lower back pain).
- Your disease activity score (DAS28) is between 2.6 and 3.2 (mild to moderate activity).
- You are taking only one type of standard RA medication (like methotrexate or a steroid) at a stable dose for at least 4 weeks.
- You have not used biologics or targeted drugs in the last 4 weeks, and you do not have other serious autoimmune diseases.
- You are willing to take a Chinese herbal decoction (Bushen Quhan Zhiwang) and follow study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether WangBi granules help control rheumatoid arthritis symptoms when used by people already taking stable methotrexate and tofacitinib. It’s mainly for people with mild-to-moderate disease activity and specific diagnostic features.
This trial tests a combination of a traditional Chinese medicine (Huoluo Pills) and a Western drug (iguratimod) for people with moderate rheumatoid arthritis. It aims to see if the combination works better than either treatment alone.
This study tests a new medication called AZD1163 for people with rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if the drug can safely reduce joint swelling and pain.
This trial tests a new treatment called SWK002 for people with rheumatoid arthritis that hasn't improved after trying multiple medications. It aims to see if SWK002 can help when other treatments have failed.
This trial combines traditional Chinese herbal medicine with standard Western treatments for people with rheumatoid arthritis that hasn't responded well to at least two prior medications. It aims to see if the combination is more effective and safe.
This study combines traditional Chinese medicine with Western medicine to treat rheumatoid arthritis. It aims to see how well this approach works for people with hard-to-treat RA or RA-related lung disease.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.